BRIEF published on 02/19/2025 at 22:10, 11 months 14 days ago Bausch Health Reports Strong Financial Performance in 2024 Adjusted EBITDA Revenue Growth Financial Performance Bausch Health 2024 Results
PRESS RELEASE published on 02/19/2025 at 22:05, 11 months 14 days ago Bausch Health Announces Fourth Quarter and Full-Year 2024 Results Bausch Health Companies Inc. announces strong Q4 and full-year 2024 financial results, achieving revenue growth in all segments and exceeding adjusted EBITDA guidance Financial Results Adjusted EBITDA Revenue Growth Bausch Health Q4 2024
BRIEF published on 02/14/2025 at 14:05, 11 months 20 days ago Bausch Health participera à la conférence financière de JP Morgan Webcast Soins De Santé Bausch Santé Pharmaceutique Conférence Sur Les Finances
BRIEF published on 02/14/2025 at 14:05, 11 months 20 days ago Bausch Health to Attend J.P. Morgan Finance Conference Healthcare Pharmaceutical Webcast Bausch Health Finance Conference
PRESS RELEASE published on 02/14/2025 at 14:00, 11 months 20 days ago Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference Bausch Health Companies Inc. to participate in 2025 J.P. Morgan Global Leveraged Finance Conference on February 24. Webcast available on Investor Relations section of Bausch Health's website Investor Relations Webcast Conference Bausch Health J.P. Morgan
BRIEF published on 02/10/2025 at 14:05, 11 months 24 days ago Bausch Health Launches 2025 Salix GI Health Scholars Program Salix Pharmaceuticals Bausch Health Higher Education GI Diseases Scholarship Program
BRIEF published on 02/10/2025 at 14:05, 11 months 24 days ago Bausch Health lance le programme de bourses d'études Salix GI Health 2025 Bausch Santé Enseignement Supérieur Programme De Bourses D'études Produits Pharmaceutiques Salix Maladies Gastro-intestinales
PRESS RELEASE published on 02/10/2025 at 14:00, 11 months 24 days ago Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program Bausch Health and Salix Pharmaceuticals launch 2025 Salix Gastrointestinal Health Scholars Program, offering scholarships for students living with GI diseases. Application deadline on May 5, 2025 Salix Pharmaceuticals Bausch Health Scholarships GI Diseases 2025
BRIEF published on 02/06/2025 at 13:10, 1 year ago Bausch Health Decides Against Sale of Bausch + Lomb Financial Performance Bausch Health Liability Management Bausch + Lomb Sale Decision
BRIEF published on 02/06/2025 at 13:10, 1 year ago Bausch Health décide de ne pas vendre Bausch + Lomb Performance Financière Bausch Santé Bausch + Lomb Décision De Vente Gestion De La Responsabilité
Published on 02/06/2026 at 15:30, 42 minutes ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 2 hours 42 minutes ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 13:30, 2 hours 42 minutes ago Canex Metals Acquires 51.93% of Gold Basin and Seeks a Court-Appointed Annual General Meeting of Gold Basin Shareholders
Published on 02/06/2026 at 13:00, 3 hours 12 minutes ago Revolve Announces US$40 Million Strategic Financing With Callaway Capital
Published on 02/06/2026 at 08:00, 8 hours 12 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 15:25, 47 minutes ago CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner
Published on 02/06/2026 at 15:21, 50 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 02/06/2026 at 16:01, 11 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 11 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 8 hours 18 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
